ORPHA:329242
Congenital chronic diarrhea with protein-losing enteropathy
Also known as: Congenital chronic diarrhea with exudative enteropathy
Query health: suspect — Only one of 2 strategies returned hits (phrase).
Publications
22
37.1th percentile
Trials
0
Interventional, condition-specific
Researchers
147
Distinct authors in sample
Gene link
DGAT1
Strong
Readiness
2/6
Stages with a signal
Clinical definition (Orphanet)
chronic diarrhea with protein-losing enteropathy is a rare, genetic, intestinal disease characterized by early-onset, chronic, non-infectious, non-bloody, watery diarrhea associated with protein-losing enteropathy which results in hypoalbuminemia, hypogammaglobulinemia and elevated stool alpha-1-antitrypsin. Patients typically present severe, intractable diarrhea, , recurrent infections and edema.
How rare: <1 / 1 000 000 — fewer than one in a million. In a city the size of Kolkata, that might mean on the order of fifteen people.
Cross-references
Joined from Mondo / Orphanet. MeSH labels may enter searches; UMLS / OMIM / NCIT are stored for reference.
- MONDO:0014375
- OMIM:615863
- UMLS:C4014516
Additional Mondo synonyms (10)
DGAT1 congenital diarrhea · DGAT1 congenital diarrhoea · congenital chronic diarrhea with exudative enteropathy · congenital chronic diarrhea with protein-losing enteropathy · congenital diarrhea caused by mutation in DGAT1 · congenital diarrhoea caused by mutation in DGAT1 · diarrhea 7, protein-losing enteropathy type · diarrhea type 7 · diarrhoea 7, protein-losing enteropathy type · diarrhoea type 7
Research stages
Trial readiness signals
Where this condition sits on an open-data research pipeline — not how close a treatment is, and not medical advice. Empty stages often mean “not in these databases under this Mondo ID,” not “impossible.”
2/6 stages with a signal
No matched interventional trial; the gene is known and literature exists — preclinical or natural-history work may still be the practical next step.
- Gene identifiedPresent
Strong — DGAT1
- LiteraturePresent
22 matched papers (20 in last 10 years) Source
- Phenotype characterisedNot checked
Not yet enriched from Monarch / HPO
- Animal modelNot checked
Not yet enriched from Monarch / Alliance
- Orphan designationNot checked
FDA/EMA orphan-drug designation not enriched yet
- Interventional trialNot found
No matched interventional trial under our ClinicalTrials.gov rules
Biology
Genes and phenotypes
Gene–disease validity from GenCC, plus phenotypes and animal models joined from Monarch Initiative via Mondo ID — not a clinical diagnosis aid.
Do we know what causes it?
Yes — we know a specific gene responsible (DGAT1).
GenCC classification: Strong.
Phenotypes (Monarch / HPO)
Not enriched in this build — Monarch phenotype joins were not run for this record.
Animal models (Monarch / Alliance)
Not enriched in this build.
Literature
Is anyone studying this?
22
22 papers have ever been published on this condition (under this name). For scale, breast cancer has over 700,000. Median papers in the last 10 years for a rare disease in this dataset (publications denominator n=5449) is 41.
22 papers since the earliest indexed year in this search — median last-10-year count for a rare disease in this dataset is 41 (publications denominator n=5449).
20 in the last 10 years · high confidence · 37.1th percentile (publications denominator)
Phrase hits: 22 · MeSH hits: 0
Who's working on it?
147
Distinct author names in 22 sampled papers — named people below.
Who's working on it?
No interventional trial matched this name; these authors publish on it in the sampled literature — a practical starting point for contact.
- 01Abdullaeva DA1 paper · 2023
Gastroenterology Department, Pediatric Republican Specialized Scientific-Practical Medical Center of the Ministry of Health of Republic of Uzbekistan, Tashkent 100179, Uzbekistan.
Papers in Europe PMC - 02Adawi A1 paper · 2026
Medical Research Club, Faculty of Medicine, Al-Quds University, Abu Deis, Palestine.
Papers in Europe PMC - 03Adesina T1 paper · 2014Papers in Europe PMC
- 04Ambedkar SN1 paper · 2025
Department of Internal Medicine, VMMC and Safdarjung Hospital, New Delhi, India.
Papers in Europe PMC - 05Amjadi Suraki S1 paper · 2024
Student Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Papers in Europe PMC - 06Anthony LB1 paper · 2019
University of Kentucky Markey Cancer Center, 800 Rose St., Lexington, KY 40536, USA. Electronic address: Lowell.anthony@uky.edu.
Papers in Europe PMC - 07Ashhab Y1 paper · 2026
Palestine-Korea Biotechnology Center, Palestine Polytechnic University, Hebron, Palestine.
Papers in Europe PMC - 08Azimova ND1 paper · 2023
Gastroenterology Department, Pediatric Republican Specialized Scientific-Practical Medical Center of the Ministry of Health of Republic of Uzbekistan, Tashkent 100179, Uzbekistan.
Papers in Europe PMC - 09Azizova GK1 paper · 2023
Gastroenterology Department, Pediatric Republican Specialized Scientific-Practical Medical Center of the Ministry of Health of Republic of Uzbekistan, Tashkent 100179, Uzbekistan.
Papers in Europe PMC - 10Bagheri-Nesami M1 paper · 2024
Traditional and Complementary Medicine Research Center, Addiction Institute, Mazandaran University of Medical Sciences, Sari, Iran.
Papers in Europe PMC
Clinical research
Is a treatment being tested?
0
interventional trials for this specific condition
No interventional trial testing a treatment matched this specific condition name on ClinicalTrials.gov (observational studies and pan-disease registries are listed separately when present).
Data as of 27 July 2026
No matched interventional trials. This is true for 73% of diseases in the trials denominator (5114 of 7003). Here are the researchers publishing on it.
high confidence · 36.5th percentile (trials denominator)
Recruiting interventional trials
From the matched ClinicalTrials.gov set
No interventional trial testing a treatment was found for this specific condition name on ClinicalTrials.gov.
See who's working on it — people publishing on this disease are often the practical next contact when no trial is listed.
Where to find support
We do not yet link condition-specific patient organisations. These umbrella groups support undiagnosed and ultra-rare families:
India — NPRD
Last verified 2026-07-26This ORPHAcode is not on our curated NPRD list (direct or Mondo-parent match). That does not decide clinical eligibility; families in India should ask a notified Centre of Excellence about current coverage.
Hand-curated for this project. ORPHAcode mappings are best-effort and may be incomplete or imprecise for umbrella categories. Parent (Mondo) matches mean the policy lists a broader category — confirm eligibility with a Centre of Excellence. Financial entitlements summarised from public policy statements and may change. This is not official government guidance.
How we counted this
Europe PMC query (preferred label + any corrected label + Orphanet and Mondo exact synonyms, stoplisted; unioned with resolved MeSH labels when available). UMLS / OMIM / NCIT cross-references are stored on the overview but are not added to the query string.
"Congenital chronic diarrhea with protein-losing enteropathy" OR "Congenital chronic diarrhea with exudative enteropathy" OR "DGAT1 congenital diarrhea" OR "DGAT1 congenital diarrhoea" OR "congenital diarrhea caused by mutation in DGAT1" OR "congenital diarrhoea caused by mutation in DGAT1" OR "diarrhea 7, protein-losing enteropathy type" OR "diarrhea type 7" OR "diarrhoea 7, protein-losing enteropathy type" OR "diarrhoea type 7"
ClinicalTrials.gov query (quoted phrases + MeSH via query.cond, plus recall-expansion terms when used):
"Congenital chronic diarrhea with protein-losing enteropathy" OR "Congenital chronic diarrhea with exudative enteropathy" OR "DGAT1 congenital diarrhea" OR "DGAT1 congenital diarrhoea" OR "congenital diarrhea caused by mutation in DGAT1" OR "congenital diarrhoea caused by mutation in DGAT1" OR "diarrhea 7, protein-losing enteropathy type" OR "diarrhea type 7" OR "diarrhoea 7, protein-losing enteropathy type" OR "diarrhoea type 7" OR "DGAT1"
Recall-expansion terms: DGAT1
Study-type breakdown: 0 interventional · 0 observational · 0 expanded access. Only interventional studies enter the trial headline.
Query health: suspect — strategies attempted: phrase, recall-expansion; with hits: phrase
Run this search on ClinicalTrials.gov
Confidence reasoning
- Preferred label is multi-word and distinctive
- No synonyms dropped by stoplist
- No label/synonym collisions with other diseases in this corpus
Ingested 2026-07-27T13:47:26.764Z